New research from Australia shows that using a targeted high-risk prevention strategy could avert around 220,000 cases of type 2 diabetes in the country by 2025.

A drug developed by Baker IDI scientists could help treat Duchenne Muscular Dystrophy (DMD),according to a study published today in Nature.

New national diabetes assessment depicts disastrous diabetes legacy for younger generations.

Overweight office workers, drivers and call centre staff who sit for long periods could improve their health by simply breaking up their sitting time with frequent activity breaks according to new research by Baker IDI Heart and Diabetes Institute.

New research involving more than half a million Australians has found that more than one in three people visiting their General Practitioner records a high blood pressure reading and that at least half do not meet their individualised blood pressure target, placing them at high risk for a future heart attack or stroke.

Robert Stewart, Baker IDI Heart and Diabetes Institute Chairman, has been recognised with an Order of Australia in the 2012 Australia Day Honours List.

A team of Baker IDI researchers led by Professor David Kaye has been awarded a five year Program Grant worth $12,406,615 for cardiovascular disease (CVD) research in the latest round of National Health and Medical Research Council (NHRMC) funding.

Australian diabetes expert, Professor Paul Zimmet AO, was elected Honorary President of the
International Diabetes Federation (IDF) at the World Diabetes Congress in Dubai this weekend.

Researchers at Baker IDI Heart & Diabetes Institute will today release the primary results from a ground-breaking, national study – VIPER-BP – which trialled an aggressive GP-led strategy to optimally manage hypertension and further reduce Australia’s risk of stroke and heart attack.

A report commissioned by Boehringer Ingelheim and developed in conjunction with experts from Baker IDI Heart & Diabetes Institute and Florey Neuroscience Institutes, reveals that more than 3,500 debilitating, often fatal and entirely ‘unnecessary’ strokes will be suffered by Australians with an irregular heartbeat (known as atrial fibrillation) this year.

Don't wait until its too late!

The achievements of Australia’s health and medical research sector and the future health of Australians are under threat.

Australian's cholesterol levels vary significantly by state, according to a new report released today by Baker IDI Heart & Diabetes Institute.

Australia’s cholesterol crossroads: An analysis of 199,331 GP patient records

Researchers at Baker IDI Heart and Diabetes Institute havel this week published the results of a world-first trial of a new minimally invasive procedure for the treatment of difficult-to-treat high blood pressure by using radio waves.

Research to extend Australia’s largest diabetes study and novel interventions for cardiovascular disease in indigenous Australians are amongst 24 Baker IDI Heart and Diabetes Institute research projects to be funded in the 2010 round of National Health and Medical Research Council (NHMRC) grants announced today by the Hon Mark Butler, MP.

The Hon Mark Butler, MP, Minister for Mental Health and Ageing, officially opened the Victor Smorgon Diabetes Centre along with the country's first Healthy Lifestyle Research Centre today.

Australia's first healthy lifestyle research facility - which will develop novel intervention strategies for people with, or at risk of, the complications of obesity - will be opened in Melbourne on Friday, 12 November.

Professor Paul Zimmet, calls for the Federal Government to act on the recommendations of the National Preventative Health Taskforce which prepared a wide-ranging action strategy in 2009 to tackle obesity.

Baker IDI Heart and Diabetes Institute, The George Institute for Global Health and Adelaide Health Technology Assessment have released for public consultation, a new evidence-based guideline on prevention, diagnosis and management of foot complications in diabetes.

Professor Paul Zimmet AO, was this week awarded the prestigious Grand Hamdan International Award for Medical Sciences in the field of Diabetes Mellitus.

Australia’s biggest cholesterol study of GP patient records has been carried out by Baker IDI researchers, with the preliminary report highlighting some surprise findings.

A team of researchers led by Baker IDI’s Dr Sally Ingliss has found remote monitoring of heart patients using telephone support and telemonitoring programs reduces deaths and hospitalisations, and may provide benefits for health care costs and quality of life.

Professor Paul Zimmet, Director Emeritus, Baker IDI Heart and Diabetes Institute has been appointed to the Government’s expert advisory panel on the proposed $450 million diabetes integrated care scheme.

Former Deputy Director of the Baker Medical Research Institute and leading cardiovascular pharmacologist, Professor James Angus AO, was among recipients acknowledged in the Queen's Birthday 2010 Honours List yesterday.

A researcher from Baker IDI Heart and Diabetes Institute who is advancing our understanding of kidney disease in diabetes has taken out a prestigious Commonwealth research award presented in Melbourne last night.

The commitment by two Aboriginal men - W & E Rubuntja - to the advancement of Indigenous people has been recognised with the naming of a new research and education building in Alice Springs in their honour.

Professor Peter Clifton, Head of Baker IDI Heart and Diabetes Institute's Nutrition Intervention Laboratory has been awarded a fellowship of the Nutrition Society of Australia. The Fellowship is the society's most senior award and is presented to individuals who have made contributions of special merit to the scientific study of nutrition and its applications to people and animals.

Medical (non-invasive) intervention alone is now superior to surgery in preventing stroke associated with severe vascular-disease narrowing of the internal carotid artery in patients without previous related stroke symptoms.

Professor Murray Esler from Baker IDI Heart and Diabetes Institute was last night awarded the prestigious Victoria Prize in recognition of his internationally renowned contributions to cardiovascular neuroscience.

A most distinguished scientist, we were lucky to have Bob visit us at Baker IDI frequently, including a longer stint for a sabbatical where he worked on the early stages of his discovery of nitric oxide and its role in endothelium mediated dilatation.

A world-first breakthrough in the treatment of high blood pressure has been pioneered at the Baker IDI Heart and Diabetes Institute in Australia, with research showing remarkable improvement in blood pressure levels for participants in a clinical trial that used a new catheter-based treatment for life threatening high blood pressure.

Baker IDI recently won a tender from the Victorian Department of Human Services (DHS) to undertake a health measurement survey called the Victorian Health Monitor (VHM).

The 2008 Ralph Reader Prize for Clinical Science was won by Gautam Vaddadi for his fantastic work in understanding the neurobiology of orthostatic intolerance.

Baker IDI Heart and Diabetes Institute, Caulfield, Australia. Adrian Cameron is completing his PhD in the area of MetS at Monash University, Department of Epidemiology and Preventive Medicine, and is supported by a post- graduate scholarship from the Heart Foundation of Australia.